Fresenius Medical Care AG

Before recording, let me remind everyone that through the course of this teleconference, King Sales Management may make comments that... Natalie, your chorus call operator.

Welcome and thank you for joining the Fresenius Medical Care Report on the third quarter earnings and FME 25. Throughout today's recorded presentation, all participants will be in a listen-only mode. The presentation will be followed by a question and answer session. If you would like to ask a question, you may press star 4 by 1 on your touchdown telephone. Press the star key followed by zero for operator assistance. I would now like to turn the conference over to Dominik, Head of Investor Relations. Please go ahead.

Thank you, Natalie. As mentioned by Natalie, we would like to welcome you to our earnings call for the third quarter 2021 and for FME25. We appreciate you joining today for an extended session and hope that all of you are equipped with foot and some water. We will start with our third quarter presentation followed by a Q&A session focused on the quarter only. At around 4.30 CET, we will then pick up on FME25 with a separate Q&A session to follow. I will start out the call by mentioning our cautionary language that is in our safe harbor statement as well as in our presentation and in all the materials that we have distributed earlier today. For further details concerning risks and uncertainties, please refer to these documents as well as to our SEC filings. In order to allow time for the FME25 presentation and a second Q&A session, we would like to limit the number of questions again to two in order to give everyone the chance to ask questions on each of the calls. It would be great if we could make this work again in both parts of the session. With us today is, of course, Rhys Powell, our CEO and Chairman of the Management Board, and Helen Gieser, our Chief Financial Officer and Chief Transformation Officer for FME25. I will now hand over to Rhys. The floor is yours.